Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr714 Inhibitors

Olr714 inhibitors represent a fascinating and intricate class of chemical compounds with a distinctive mode of action centered around the inhibition of the Olr714 receptor, a member of the olfactory receptor family. Olr714, part of the G protein-coupled receptor (GPCR) superfamily, is primarily involved in the detection of odor molecules, playing a crucial role in the olfactory signaling pathway. These inhibitors are designed to bind selectively to the Olr714 receptor, thereby obstructing its normal function. The precise interaction typically involves binding to the active site or allosteric sites of the receptor, preventing the receptor from undergoing the conformational changes necessary for signaling. This can result in altered olfactory perceptions, providing a unique tool for studying the molecular mechanisms of olfaction.

From a chemical standpoint, Olr714 inhibitors exhibit a diverse range of structures, often characterized by complex aromatic systems, heterocyclic moieties, and various functional groups that enhance their binding affinity and specificity. The synthesis of these inhibitors requires advanced organic chemistry techniques, often involving multiple steps of selective functionalization, protection-deprotection strategies, and careful stereochemical control to achieve the desired molecular configuration. Analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography are extensively employed to confirm the structural integrity and purity of these compounds. Additionally, computational modeling and molecular docking studies play a crucial role in understanding the binding interactions and optimizing the design of more potent and selective inhibitors. This chemical diversity not only highlights the synthetic challenges but also underscores the potential of these compounds as powerful molecular probes for dissecting the intricate signaling pathways mediated by the Olr714 receptor.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Inhibits multiple tyrosine kinases, potentially affecting angiogenesis and growth factor signaling.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, potentially impacting cell cycle regulation proteins.

Bicalutamide

90357-06-5sc-202976
sc-202976A
100 mg
500 mg
$42.00
$146.00
27
(1)

Androgen receptor antagonist, potentially affecting proteins in androgen receptor signaling pathways.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$175.00
$983.00
2
(1)

BCR-ABL and tyrosine kinase inhibitor, potentially affecting proteins in leukemia signaling pathways.

Acalabrutinib

1420477-60-6sc-507392
250 mg
$255.00
(0)

Bruton's tyrosine kinase inhibitor, potentially impacting proteins in B-cell receptor signaling pathways.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Multi-kinase inhibitor, potentially affecting proteins in angiogenesis, oncogenesis, and the tumor microenvironment.

Abiraterone

154229-19-3sc-460288
10 mg
$276.00
(0)

CYP17 inhibitor, potentially affecting steroid synthesis and related signaling pathways.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Inhibits VEGFR, EGFR, and RET tyrosine kinases, potentially affecting proteins in associated signaling pathways.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Bruton's tyrosine kinase inhibitor, potentially impacting proteins in B-cell receptor signaling pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, potentially disrupting DNA repair pathways and affecting protein function.